Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Studies on schedules for human rabies immunization].

R Shao1, J Qian, C Ding

  • 1Sanitation and Anti-epidemic Station of Yancheng City, Jiangsu Province, Yancheng, 224002, China.

Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]
|February 28, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Research progress in diagnosis and treatment of non-tumorous salivary gland diseases].

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences·2026
Same author

[Exploration of ribosomal DNA copy number as an early biomarker for exposure to chemical carcinogens].

Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases·2025
Same author

First Constraint on Atmospheric Millicharged Particles with the LUX-ZEPLIN Experiment.

Physical review letters·2025
Same author

New Constraints on Cosmic Ray-Boosted Dark Matter from the LUX-ZEPLIN Experiment.

Physical review letters·2025
Same author

Dark Matter Search Results from 4.2  Tonne-Years of Exposure of the LUX-ZEPLIN (LZ) Experiment.

Physical review letters·2025
Same author

Steatotic liver disease is a marker of multimorbidity, not underlying cirrhosis, in older adults.

Npj gut and liver·2025

Interferon (IFN) combined with a 2-2-1 rabies vaccine schedule enhances immune response compared to standard schedules. This combination shows improved antibody titers and protective levels, demonstrating its feasibility and effectiveness in rabies immunization.

Area of Science:

  • Immunology
  • Vaccinology
  • Virology

Context:

  • Rabies remains a significant global health threat, necessitating effective vaccination strategies.
  • Current rabies vaccine schedules require optimization for enhanced immunogenicity and faster protection.

Purpose:

  • To evaluate the feasibility of an interferon (IFN)-alpha plus a 2-2-1 rabies vaccine immunization schedule.
  • To compare the immunogenicity of the IFN-plus-2-2-1 schedule against a simple 2-2-1 schedule and a WHO-recommended routine schedule.
  • To explore the immune regulatory mechanisms of IFN in rabies vaccination.

Summary:

  • The IFN plus 2-2-1 schedule demonstrated superior antibody geometric mean titers (GMT) on days 7, 14, and 45 compared to the simple 2-2-1 and routine schedules.
  • Higher antibody conversion rates and a greater proportion of individuals achieving protective antibody levels were observed with the IFN-enhanced schedule by day 14.

Related Experiment Videos

  • Both 2-2-1 schedules showed improved outcomes over the routine schedule, with no significant differences in adverse reactions across groups.

    • Impact:

    • The findings suggest that low-dose IFN can significantly boost the immune response to rabies vaccines.
    • The IFN plus 2-2-1 schedule represents a potentially more effective immunization strategy for rabies.
    • This research contributes to understanding IFN's role in modulating vaccine-induced immunity, paving the way for improved vaccine protocols.